Insight Molecular Diagnostics Inc.IMDXEarnings & Financial Report
Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
IMDX Q3 2025 Key Financial Metrics
Revenue
$260.0K
Gross Profit
$139.0K
Operating Profit
$-11.0M
Net Profit
$-10.9M
Gross Margin
53.5%
Operating Margin
-4249.2%
Net Margin
-4174.6%
YoY Growth
126.1%
EPS
$-0.34
Financial Flow
Insight Molecular Diagnostics Inc. Q3 2025 Financial Summary
Insight Molecular Diagnostics Inc. reported revenue of $260.0K for Q3 2025, with a net profit of $-10.9M (-4174.6% margin). Cost of goods sold was $121.0K, operating expenses totaled $11.2M.
Key Financial Metrics
| Total Revenue | $260.0K |
|---|---|
| Net Profit | $-10.9M |
| Gross Margin | 53.5% |
| Operating Margin | -4249.2% |
| Report Period | Q3 2025 |
Insight Molecular Diagnostics Inc. Annual Revenue by Year
Insight Molecular Diagnostics Inc. annual revenue history includes year-by-year totals (for example, 2024 revenue was $1.9M).
| Year | Annual Revenue |
|---|---|
| 2024 | $1.9M |
| 2023 | $1.5M |
| 2022 | $958.0K |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $314000 | $176000 | $104000 | $115000 | $1.5M | $2.1M | $518000 | $260000 |
| YoY Growth | 108.8% | -40.7% | -77.5% | -73.2% | 373.2% | 1114.8% | 398.1% | 126.1% |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $74.9M | $71.0M | $74.7M | $70.2M | $35.1M | $60.4M | $50.5M | $43.9M |
| Liabilities | $49.3M | $54.1M | $52.0M | $60.5M | $47.4M | $50.1M | $49.4M | $53.1M |
| Equity | $20.5M | $11.6M | $22.7M | $9.7M | $-12.3M | $10.2M | $1.1M | $-9.2M |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-4.6M | $-3.8M | $-6.0M | $-5.6M | $-5.4M | $-5.9M | $-6.3M | $-4.5M |
More Companies
THC
TENET HEALTHCARE CORP
Revenue
$5.3B
Net Profit
$579.0M
FMS
Fresenius Medical Care AG
EHC
Encompass Health Corp
Revenue
$1.5B
Net Profit
$126.5M
BTSG
BrightSpring Health Services, Inc.
Revenue
$3.3B
Net Profit
$55.8M
OPCH
Option Care Health, Inc.
Revenue
$1.4B
Net Profit
$51.8M
CON
Concentra Group Holdings Parent, Inc.
Revenue
$572.8M
Net Profit
$48.3M
NHC
NATIONAL HEALTHCARE CORP
Revenue
$382.7M
Net Profit
$39.2M
SGRY
Surgery Partners, Inc.
Revenue
$821.5M
Net Profit
$-22.7M
SEM
SELECT MEDICAL HOLDINGS CORP
Revenue
$1.4B
Net Profit
$28.8M
DHC
DIVERSIFIED HEALTHCARE TRUST
Revenue
$388.7M
Net Profit
$-164.0M